Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus

Antiviral Research

Volumn 66, Issue 2-3, 2005, Pages 159-163

  Saijo, Masayuki ^a   Morikawa, Shigeru ^a   Fukushi, Shuetsu ^a   Mizutani, Tetsuya ^a   Hasegawa, Hideki ^a   Nagata, Noriyo ^a   Iwata, Naoko ^a   Kurane, Ichiro ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Coronavirus; Mizoribine; Ribavirin; SARS

Indexed keywords

MIZORIBINE; RIBAVIRIN;

ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; IC 50; NONHUMAN; PRIORITY JOURNAL; SARS CORONAVIRUS; VERO CELL; VIRUS CULTURE; VIRUS PLAQUE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; MICROBIAL SENSITIVITY TESTS; RIBAVIRIN; RIBONUCLEOSIDES; SARS VIRUS; VERO CELLS; VIRUS REPLICATION;

CORONAVIRUS; SARS COV;

EID: 19344370471     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2005.01.003     Document Type: Article

References (32)

1. C.M. Chu, V.C. Cheng, I.F. Hung, M.M. Wong, K.H. Chan, K.S. Chan, R.Y. Kao, L.L. Poon, C.L. Wong, Y. Guan, J.S. Peiris, and K.Y. Yuen Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings Thorax 59 2004 252 256
2. J. Cinatl, B. Morgenstern, G. Bauer, P. Chandra, H. Rabenau, and H.W. Doerr Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus Lancet 361 2003 2045 2046
3. C. Drosten, S. Gunther, W. Preiser, S. van der Werf, H.R. Brodt, S. Becker, H. Rabenau, M. Panning, L. Kolesnikova, R.A. Fouchier, A. Berger, A.M. Burguiere, J. Cinatl, M. Eickmann, N. Escriou, K. Grywna, S. Kramme, J.C. Manuguerra, S. Muller, V. Rickerts, M. Sturmer, S. Vieth, H.D. Klenk, A.D. Osterhaus, H. Schmitz, and H.W. Doerr Identification of a novel coronavirus in patients with severe acute respiratory syndrome N. Engl. J. Med. 348 2003 1967 1976
4. B. Eriksson, E. Helgstrand, N.G. Johansson, A. Larsson, A. Misiorny, J.O. Noren, L. Philipson, K. Stenberg, G. Stening, S. Stridh, and B. Öberg Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate Antimicrob. Agents Chemother. 11 1977 946 951
5. B.B. Goswami, E. Borek, O.K. Sharma, J. Fujitaki, and R.A. Smith The broad spectrum antiviral agent ribavirin inhibits capping of mRNA Biochem. Biophys. Res. Commun. 89 1979 830 836
6. R. He, A. Adonov, M. Traykova-Adonova, J. Cao, T. Cutts, E. Grudesky, Y. Deschambaul, J. Berry, M. Drebot, and X. Li Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid Biochem. Biophys. Res. Commun. 320 2004 1199 1203
7. L.E. Hensley, L.E. Fritz, P.B. Jahrling, C.L. Karp, J.W. Huggins, and T.W. Geisbert Interferon-beta 1a and SARS coronavirus replication Emerg. Infect. Dis. 10 2004 317 319
8. J.C. Ho, G.C. Ooi, T.Y. Mok, J.W. Chan, I. Hung, B. Lam, P.C. Wong, P.C. Li, P.L. Ho, W.K. Lam, C.K. Ng, M.S. Ip, K.N. Lai, M. Chan-Yeung, and K.W. Tsang High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome Am. J. Respir. Crit. Care Med. 168 2003 1449 1456
9. M. Hosoya, S. Shigeta, T. Ishii, H. Suzuki, and E. De Clercq Comparative inhibitory effects of various nucleoside and nonnucleoside analogues on replication of influenza virus types A and B in vitro and in ovo J. Infect. Dis. 168 1993 641 646
10. E. Keyaerts, L. Vijgen, L. Chen, P. Maes, G. Hedenstierna, and M. Van Ranst Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N- acetylpenicillamine, a nitric oxide donor compound Int. J. Infect. Dis. 8 2004 223 226
11. J.J. Kirsi, J.A. North, P.A. McKernan, B.K. Murray, P.G. Canonico, J.W. Huggins, P.C. Srivastava, and R.K. Robins Broad-spectrum antiviral activity of 2-beta-d-ribofuranosylselenazole-4-carboxamide, a new antiviral agent Antimicrob. Agents Chemother. 24 1983 353 361
12. T.G. Ksiazek, D. Erdman, C.S. Goldsmith, S.R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J.A. Comer, W. Lim, P.E. Rollin, S.F. Dowell, A.E. Ling, C.D. Humphrey, W.J. Shieh, J. Guarner, C.D. Paddock, P. Rota, B. Fields, J. DeRisi, J.Y. Yang, N. Cox, J.M. Hughes, J.W. LeDuc, W.J. Bellini, and L.J. Anderson A novel coronavirus associated with severe acute respiratory syndrome N. Engl. J. Med. 348 2003 1953 1966
13. N. Lee, D. Hui, A. Wu, P. Chan, P. Cameron, G.M. Joynt, A. Ahuja, M.Y. Yung, C.B. Leung, K.F. To, S.F. Lui, C.C. Szeto, S. Chung, and J.J. Sung A major outbreak of severe acute respiratory syndrome in Hong Kong N. Engl. J. Med. 348 2003 1986 1994
14. M.R. Loutfy, L.M. Blatt, K.A. Siminovitch, S. Ward, B. Wolff, H. Lho, D.H. Pham, H. Deif, E.A. LaMere, M. Chang, K.C. Kain, G.A. Farcas, P. Ferguson, M. Latchford, G. Levy, J.W. Dennis, E.K. Lai, and E.N. Fish Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study JAMA 290 2003 3222 3228
15. J.K. Lowe, L. Brox, and J.F. Henderson Consequences of inhibition of guanine nucleotide synthesis by mycophenolic acid and virazole Cancer Res. 37 1977 736 743
16. W.E. Muller, A. Maidhof, H. Taschner, and R.K. Zahn Virazole (1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide); a cytostatic agent Biochem. Pharmacol. 26 1977 1071 1075
17. S. Pancheva, D. Dundarova, and M. Remichkova Potentiating effect of mizoribine on the anti-herpes virus activity of acyclovir Z. Naturforsch. [C] 57 2002 902 904
18. S.M. Poutanen, D.E. Low, B. Henry, S. Finkelstein, D. Rose, K. Green, R. Tellier, R. Draker, D. Adachi, M. Ayers, A.K. Chan, D.M. Skowronski, I. Salit, A.E. Simor, A.S. Slutsky, P.W. Doyle, M. Krajden, M. Petric, R.C. Brunham, and A.J. McGeer Identification of severe acute respiratory syndrome in Canada N. Engl. J. Med. 348 2003 1995 2005
19. B. Sainz Jr., E.C. Mossel, C.J. Peters, and R.F. Garry Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) Virology 329 2004 11 17
20. S. Shigeta Recent progress in antiviral chemotherapy for respiratory syncytial virus infections Expert Opin. Investig. Drugs 9 2000 221 235
21. K. Shiraki, M. Ishibashi, T. Okuno, Y. Kokado, S. Takahara, K. Yamanishi, T. Sonoda, and M. Takahashi Effects of cyclosporine, azathioprine, mizoribine, and prednisolone on replication of human cytomegalovirus Transplant. Proc. 22 1990 1682 1685
22. D.F. Smee, R.W. Sidwell, S.M. Clark, B.B. Barnett, and R.S. Spendlove Inhibition of rotaviruses by selected antiviral substances: mechanisms of viral inhibition and in vivo activity Antimicrob. Agents Chemother. 21 1982 66 73
23. D.G. Streeter, J.T. Witkowski, G.P. Khare, R.W. Sidwell, R.J. Bauer, R.K. Robins, and L.N. Simon Mechanism of action of 1-β-d-ribofuranosyl-1,2,4- triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent Proc. Natl. Acad. Sci. U.S.A. 70 1973 1174 1178
24. U. Stroher, A. DiCaro, Y. Li, J.E. Strong, F. Aoki, F. Plummer, S.M. Jones, and H. Feldmann Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha J. Infect. Dis. 189 2004 1164 1167
25. L.J. Stuyver, S. Lostia, S.E. Patterson, J.L. Clark, K.A. Watanabe, M.J. Otto, and K.W. Pankiewicz Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents Antiviral Chem. Chemother. 13 2002 345 352
26. P. Toltzis, K. O'Connell, and J.L. Patterson Effect of phosphorylated ribavirin on vesicular stomatitis virus transcription Antimicrob. Agents Chemother. 32 1988 492 497
27. K.W. Tsang, P.L. Ho, G.C. Ooi, W.K. Yee, T. Wang, M. Chan-Yeung, W.K. Lam, W.H. Seto, L.Y. Yam, T.M. Cheung, P.C. Wong, B. Lam, M.S. Ip, J. Chan, K.Y. Yuen, and K.N. Lai A cluster of cases of severe acute respiratory syndrome in Hong Kong N. Engl. J. Med. 348 2003 1977 1985
28. C.J. Wu, J.T. Jan, C.M. Chen, H.P. Hsieh, D.R. Hwang, H.W. Liu, C.Y. Liu, H.W. Huang, S.C. Chen, C.F. Hong, R.K. Lin, Y.S. Chao, and J.T. Hsu Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide Antimicrob. Agents Chemother. 48 2004 2693 2696
29. N. Yamamoto, R. Yang, Y. Yoshinaka, S. Amari, T. Nakano, J. Cinatl, H. Rabenau, H.W. Doerr, G. Hunsmann, A. Otaka, H. Tamamura, N. Fujii, and N. Yamamoto HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus Biochem. Biophys. Res. Commun. 318 2004 719 725
30. S. Yokota Mizoribine: mode of action and effects in clinical use Pediatr. Int. 44 2002 196 198
31. Z. Zhao, F. Zhang, M. Xu, K. Huang, W. Zhong, W. Cai, Z. Yin, S. Huang, Z. Deng, M. Wei, J. Xiong, and P.M. Hawkey Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China J. Med. Microbiol. 52 2003 715 720
32. G. Zhaori Antiviral treatment of SARS: can we draw any conclusions CMAJ 169 2003 1165 1166